Announcements Trials

Browse Landscape

Phase

Status

Completed 13 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Carboplatin 127 Cisplatin 125 Drug Therapy 116 Bevacizumab 102 Capecitabine 100 Oxaliplatin 99 Radiotherapy 97 Gemcitabine 87 tislelizumab 86 Paclitaxel 86 Cyclophosphamide 85 pembrolizumab 77 Specimen Handling 77 toripalimab 70 Magnetic Resonance Spectroscopy 63 Injections 63 Fluorouracil 63 sintilimab 58 Surgical Procedures, Operative 58 anlotinib 53 Docetaxel 52 130-nm albumin-bound paclitaxel 51 fludarabine 47 Standard of Care 45 Pemetrexed 45 Immune Checkpoint Inhibitors 45 Blood Specimen Collection 43 venetoclax 42 Leucovorin 42 lenvatinib 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Raloxifene Hydrochloride × Clear all

NCT07470606 2026-03-13

MemoryRT

The University of Texas Health Science Center at San Antonio

Phase 2 Not yet recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡